← Back to Search

Tobacco Regulations for Smoking

N/A
Waitlist Available
Research Sponsored by Mikhail N Koffarnus
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least 21 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up collected daily from study week 1 to study week 9

Summary

This trial aims to investigate the impact of proposed tobacco regulations in rural Appalachian Kentucky. The study will focus on three specific regulations and how they affect tobacco users in this area. Participants will take surveys, participate

Who is the study for?
This trial is for adults over 21 in Appalachian Kentucky who use nicotine or tobacco daily, understand English, and don't plan to quit or seek treatment within the next 9 weeks. It aims to help a diverse rural area by studying proposed tobacco regulations.
What is being tested?
Researchers are testing how three potential regulations on tobacco products might change user behavior. Participants will engage with online surveys, simulated shopping in an Experimental Tobacco Marketplace, and track their usage over a 9-week period.
What are the potential side effects?
Since this study involves behavioral research rather than medical interventions, traditional physical side effects aren't expected. However, participants may experience changes in their smoking habits due to the regulatory scenarios presented.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am at least 21 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~collected daily from study week 1 to study week 9
This trial's timeline: 3 weeks for screening, Varies for treatment, and collected daily from study week 1 to study week 9 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Aggregate behavioral economic demand across all participants under the proposed regulatory environments
Aggregate behavioral economic substitution across all participants under the proposed regulatory environments
Secondary study objectives
Activity Level Questionnaire - Substance Use Version (ALQ-SUV)
Breath Carbon Monoxide (CO)
Delay Discounting Tasks
+8 more

Trial Design

4Treatment groups
Active Control
Placebo Group
Group I: Rural - Very Low Nicotine CigaretteActive Control4 Interventions
Participants who reside in rural locales of Appalachian KY and receive very low nicotine cigarettes during the sampling period.
Group II: Peri-Urban - Very Low Nicotine CigaretteActive Control4 Interventions
Participants who reside in peri-urban locales of Appalachian KY and receive very low nicotine cigarettes during the sampling period.
Group III: Rural - Conventional CigarettePlacebo Group3 Interventions
Participants who reside in rural locales of Appalachian KY and receive conventional cigarettes during the sampling period.
Group IV: Peri-Urban - Conventional CigarettePlacebo Group3 Interventions
Participants who reside in peri-urban locales of Appalachian KY and receive conventional cigarettes during the sampling period.

Find a Location

Who is running the clinical trial?

Mikhail N KoffarnusLead Sponsor
2 Previous Clinical Trials
430 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,587 Previous Clinical Trials
3,328,075 Total Patients Enrolled
69 Trials studying Smoking
22,831 Patients Enrolled for Smoking
~315 spots leftby Feb 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top